AgroFresh Solutions Reports Results for Third Quarter and First Nine Months of 2022
- Third quarter 2022 net sales were
$47.8 million , a decrease of 2.9% (or an increase of 3.1% on a constant currency basis) versus the prior year period; net sales increased 3.0% (or 8.1% on a constant currency basis) for the nine months endedSeptember 30, 2022 versus the prior year period. - Diversification revenue (all other product categories excluding SmartFresh™ for apples) grew 12.7% for the trailing twelve month period ended
September 30, 2022 versus the twelve months endedSeptember 30, 2021 , and represented 44.5% of consolidated revenues during the twelve months endedSeptember 30, 2022 . - Net loss of
$4.6 million for the third quarter of 2022, as compared to net income of$0.8 million for the third quarter of 2021. For the nine months endedSeptember 30, 2022 net loss of$26 .2 million versus a net loss of$8 .3 million in the prior year period. - Adjusted EBITDA1 of
$17.9 million for the third quarter of 2022, compared to$20.5 million in the prior year period. For the nine months endedSeptember 30, 2022 Adjusted EBITDA decreased 0.7% to$35.3 million compared to the prior year period Adjusted EBITDA of$35.6 million .
“The third quarter marks the beginning of our Northern Hemisphere season. We posted third quarter operational2 revenue growth of 3.1% on a constant currency basis, despite weather related events in
1Adjusted EBITDA is a non-GAAP financial measure. Please see the information under “Non-GAAP Financial Measures” below for a description of Adjusted EBITDA and the table at the end of this press release for a reconciliation of this Non-GAAP financial measure to GAAP results.
2Operational growth (a non-GAAP financial measure) is defined as growth excluding the impact of foreign exchange.
Financial Highlights for the Third Quarter of 2022
Net sales for the third quarter of 2022 decreased 2.9% to
Gross profit for the third quarter of 2022 was
Research and development costs were
Selling, general and administrative expenses were
Third quarter 2022 net loss was
Adjusted EBITDA1 was
As of
Financial Highlights for the First Nine Months of 2022
Net sales for the nine months ended
Gross profit for the nine months ended
Research and development costs were
Selling, general and administrative expenses increased 0.8% to
For the nine months ended
Adjusted EBITDA1 was
Conference Call
The Company will host a conference call and webcast today at
A replay of the conference call will be archived on the Company’s website and telephonic playback will be available from
Non-GAAP Financial Measures
This press release contains certain non-GAAP financial measures, including EBITDA, Adjusted EBITDA and net sales on a constant currency basis. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they are used by the Company’s management to evaluate the Company’s performance, including for incentive bonuses and bank covenant reporting. Management believes that these measures enhance a reader’s understanding of the operating and financial performance of the Company and facilitate a better comparison between fiscal periods. EBITDA excludes income taxes, interest expense and depreciation and amortization, whereas Adjusted EBITDA further excludes items that are non-cash, infrequent, or non-recurring, such as share-based compensation, severance, litigation and M&A related costs, to provide further meaningful information to evaluate the Company’s performance.
The Company does not intend for the non-GAAP financial measures contained in this release to be a substitute for any GAAP financial information. Readers of this press release should use these non-GAAP financial measures only in conjunction with the comparable GAAP financial measures. Reconciliations of the non-GAAP financial measures EBITDA and Adjusted EBITDA, as well as constant currency net sales, to their most comparable GAAP measures are provided in the table at the end of this press release.
About
™Trademark of
Forward-Looking Statements
In addition to historical information, this release may contain “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in this release that address activities, events or developments that the Company expects or anticipates will or may occur in the future are forward-looking statements and are identified with, but not limited to, words such as “anticipate”, “believe”, “expect”, “estimate”, “plan”, “outlook”, and “project” and other similar expressions (or the negative versions of such words or expressions). Forward-looking statements include, without limitation, information concerning the Company’s possible or assumed future results of operations, including all statements regarding financial guidance, anticipated future growth, business strategies, competitive position, industry environment, potential growth opportunities and the effects of regulation. These statements are based on management's current expectations and beliefs, as well as a number of assumptions concerning future events. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s management’s control that could cause actual results to differ materially from the results discussed in the forward-looking statements. These risks include, without limitation, the risk of increased competition; the ability of the business to grow and manage growth profitably; risks associated with the Company’s substantial level of indebtedness; risks associated with acquisitions and investments; changes in applicable laws or regulations; conditions in the global economy, including the effects of the coronavirus outbreak, inflationary and currency exchange rate impacts; and the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors. Additional risks and uncertainties are identified and discussed in the Company’s filings with the
Contact:
For
Jeff.Sonnek@icrinc.com
646-277-1263
AgroFresh Solutions, Inc.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
ASSETS | |||||||
Current Assets: | |||||||
Cash and cash equivalents | |||||||
Accounts receivable, net of allowance for doubtful accounts of |
60,491 | 53,538 | |||||
Inventories | 24,757 | 19,780 | |||||
Other current assets | 23,193 | 19,878 | |||||
Total Current Assets | 144,088 | 155,126 | |||||
Property and equipment, net | 10,968 | 11,986 | |||||
Intangible assets, net | 514,128 | 546,652 | |||||
Deferred income tax assets | 8,445 | 7,392 | |||||
Other assets | 11,302 | 11,406 | |||||
TOTAL ASSETS | |||||||
LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS’ EQUITY | |||||||
Current Liabilities: | |||||||
Accounts payable | |||||||
Current portion of long-term debt | 3,139 | 3,362 | |||||
Income taxes payable | 2,999 | 2,382 | |||||
Accrued expenses and other current liabilities | 30,925 | 26,994 | |||||
Total Current Liabilities | 49,445 | 49,707 | |||||
Long-term debt | 253,240 | 254,194 | |||||
Other noncurrent liabilities | 7,061 | 6,256 | |||||
Deferred income tax liabilities | 31,933 | 34,833 | |||||
Total Liabilities | 341,679 | 344,990 | |||||
Commitments and contingencies (see Note 21) | |||||||
Temporary Equity: | |||||||
Series B convertible preferred stock, par value |
158,398 | 149,386 | |||||
Redeemable non-controlling interest | 6,877 | 7,787 | |||||
Stockholders’ Equity: | |||||||
Common stock, par value |
5 | 5 | |||||
Preferred stock, par value |
— | — | |||||
(3,885 | ) | (3,885 | ) | ||||
Additional paid-in capital | 512,645 | 529,303 | |||||
Accumulated deficit | (273,901 | ) | (248,660 | ) | |||
Accumulated other comprehensive loss | (52,887 | ) | (46,364 | ) | |||
Total Stockholders' Equity | 181,977 | 230,399 | |||||
TOTAL LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS' EQUITY |
AgroFresh Solutions, Inc.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
Three Months Ended |
Nine Months Ended |
||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||
Net sales | |||||||||||||
Cost of sales (excluding amortization of intangibles, shown separately below) | 15,552 | 15,035 | 36,767 | 32,453 | |||||||||
Gross profit | 32,212 | 34,143 | 76,638 | 77,641 | |||||||||
Research and development expenses | 3,150 | 3,329 | 9,085 | 10,123 | |||||||||
Selling, general, and administrative expenses | 13,537 | 12,282 | 39,763 | 39,453 | |||||||||
Amortization of intangibles | 10,606 | 10,830 | 32,032 | 32,092 | |||||||||
Operating loss | 4,919 | 7,702 | (4,242 | ) | (4,027 | ) | |||||||
Other (expense) income | (35 | ) | (299 | ) | 479 | 14,053 | |||||||
(Loss) gain on foreign currency exchange | (3,299 | ) | (918 | ) | (9,373 | ) | 436 | ||||||
Interest expense, net | (5,664 | ) | (5,465 | ) | (15,703 | ) | (16,571 | ) | |||||
(Loss) income before income taxes | (4,079 | ) | 1,020 | (28,839 | ) | (6,109 | ) | ||||||
Income taxes expense (benefit) | 535 | 208 | (2,687 | ) | 2,175 | ||||||||
Net (loss) income including non-controlling interest | (4,614 | ) | 812 | (26,152 | ) | (8,284 | ) | ||||||
Less: Net loss attributable to non-controlling interest | (476 | ) | (182 | ) | (911 | ) | (441 | ) | |||||
Net (loss) income attributable to |
(4,138 | ) | 994 | (25,241 | ) | (7,843 | ) | ||||||
Less: Dividends on convertible preferred stock | 6,663 | 6,248 | 19,632 | 18,580 | |||||||||
Net loss attributable to |
( |
) | ( |
) | ( |
) | ( |
) | |||||
Loss per share of common shares: | |||||||||||||
Basic | ( |
) | ( |
) | $(0.86 | ) | $(0.51 | ) | |||||
Diluted | ( |
) | ( |
) | $(0.86 | ) | $(0.51 | ) | |||||
Weighted average shares of common stock outstanding: | |||||||||||||
Basic | 52,400 | 51,583 | 52,077 | 51,323 | |||||||||
Diluted | 52,400 | 51,583 | 52,077 | 51,323 |
Non-GAAP Measures
The following tables set forth the non-GAAP financial measures of EBITDA, Adjusted EBITDA and constant currency net sales. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they are used by the Company’s management to evaluate the Company’s performance (including for incentive bonuses and bank covenant reporting), are more indicative of future operating performance of the Company, and facilitate a better comparison among fiscal periods. These non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP.
The following is a reconciliation between the non-GAAP financial measures of EBITDA and Adjusted EBITDA to their most directly comparable GAAP financial measure, net loss including non-controlling interest:
Three Months Ended |
Nine Months Ended |
|||||||||||
(in thousands) | 2022 | 2021 | 2022 | 2021 | ||||||||
GAAP net (loss) income including non-controlling interest | ( |
) | ( |
) | ( |
) | ||||||
Depreciation and amortization | 11,360 | 11,522 | 34,252 | 34,122 | ||||||||
Interest expense (1) | 5,664 | 5,465 | 15,703 | 16,571 | ||||||||
Income taxes expense (benefit) | 535 | 208 | (2,687 | ) | 2,175 | |||||||
Non-GAAP EBITDA | ||||||||||||
Adjustments: | ||||||||||||
Share-based compensation | 1,096 | 976 | 3,411 | 2,147 | ||||||||
Severance related costs (2) | 74 | 29 | 918 | 1,616 | ||||||||
Other non-recurring costs (3) | 525 | 242 | 1,035 | 1,762 | ||||||||
Loss (gain) on foreign currency exchange (4) | 3,299 | 918 | 9,373 | (436 | ) | |||||||
Other income (5) | — | 301 | (515 | ) | 301 | |||||||
Litigation settlement | — | — | — | (14,392 | ) | |||||||
Total Adjustments | 4,994 | 2,466 | 14,222 | (9,002 | ) | |||||||
Non-GAAP Adjusted EBITDA |
(1) | Interest on debt and accretion for debt discounts. |
(2) | Severance costs related to continued focus on cost control initiatives and restructuring. |
(3) | Costs related to certain professional and other infrequent or non-recurring fees, including those associated with refinancing activities, litigation and M&A related fees. |
(4) | Net gains and losses resulting from transactions denominated in a currency other than the Company's functional currency. |
(5) | Non-recurring data compensation income. |
The following is a reconciliation between net sales on a non-GAAP operational basis to GAAP net sales:
Three Months Ended |
Nine Months Ended |
||||||||
(in thousands) | 2022 | 2021 | 2022 | 2021 | |||||
GAAP net sales | |||||||||
Impact from changes in foreign currency exchange rates | 2,963 | — | 5,611 | — | |||||
Non-GAAP operational net sales (1) |
(1) | The Company provides net sales on a constant currency basis to enhance investors’ understanding of underlying business trends and operating performance, by removing the impact of foreign currency exchange rate fluctuations. The impact from foreign currency, calculated on a constant currency basis, is determined by applying prior period average exchange rates to current year results. |
The following is a reconciliation between gross profit on a non-GAAP operational basis to GAAP gross profit:
Three Months Ended |
Nine Months Ended |
||||||||
(in thousands) | 2022 | 2021 | 2022 | 2021 | |||||
GAAP gross profit | |||||||||
Impact from changes in foreign currency exchange rates | 2,982 | — | 2,216 | — | |||||
Non-GAAP operational gross profit (1) |
(1) | The Company provides gross profit on a constant currency basis to enhance investors’ understanding of underlying business trends and operating performance, by removing the impact of foreign currency exchange rate fluctuations. The impact from foreign currency, calculated on a constant currency basis, is determined by applying prior period average exchange rates to current year results. |

Source: AgroFresh Solutions, Inc.